Annual Operating Margin
-60.15%
+154.33 K%+99.96%
31 December 2023
Summary:
CRISPR Therapeutics AG annual operating profit margin is currently -60.15%, with the most recent change of +154.33 thousand% (+99.96%) on 31 December 2023. During the last 3 years, it has risen by +65.21 thousand% (+99.91%). CRSP annual operating margin is now -247.03% below its all-time high of 40.91%, reached on 31 December 2021.CRSP Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
N/A
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly operating profit margin is not available.CRSP Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | - |
| 3 y3 years | +99.9% | - |
| 5 y5 years | +98.8% | - |
CRSP Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -247.0% | +100.0% | ||
| 5 y | 5 years | -247.0% | +100.0% | ||
| alltime | all time | -247.0% | +100.0% |
CRISPR Therapeutics AG Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -60.15%(-100.0%) | 34.79%(-125.6%) |
| June 2023 | - | -136.03%(+110.9%) |
| Mar 2023 | - | -64.49%(-100.0%) |
| Dec 2022 | -154.39 K%(<-9900.0%) | -2.19 M%(+1029.9%) |
| Sept 2022 | - | -194.03 K%(+67.3%) |
| June 2022 | - | -115.99 K%(+17.3%) |
| Mar 2022 | - | -98.86 K%(+8278.5%) |
| Dec 2021 | 40.91%(-100.1%) | -1179.93%(-97.0%) |
| Sept 2021 | - | -39.16 K%(<-9900.0%) |
| June 2021 | - | 84.72%(-100.1%) |
| Mar 2021 | - | -56.70 K%(+2.1%) |
| Dec 2020 | -65.27 K%(<-9900.0%) | -55.55 K%(-11.0%) |
| Sept 2020 | - | -62.43 K%(-66.0%) |
| June 2020 | - | -183.38 K%(+291.3%) |
| Mar 2020 | - | -46.87 K%(<-9900.0%) |
| Dec 2019 | 16.14% | 14.26%(-78.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | 65.67%(-100.4%) |
| June 2019 | - | -17.29 K%(+17.1%) |
| Mar 2019 | - | -14.76 K%(-62.5%) |
| Dec 2018 | -5087.80%(+3126.5%) | -39.33 K%(+347.9%) |
| Sept 2018 | - | -8780.11%(+156.2%) |
| June 2018 | - | -3427.02%(+72.4%) |
| Mar 2018 | - | -1988.00%(<-9900.0%) |
| Dec 2017 | -157.69%(-88.0%) | 3.01%(-100.3%) |
| Sept 2017 | - | -987.43%(+66.0%) |
| June 2017 | - | -594.81%(-22.5%) |
| Mar 2017 | - | -767.44%(-28.9%) |
| Dec 2016 | -1319.33%(-87.3%) | -1079.78%(+14.5%) |
| Sept 2016 | - | -943.19%(-54.7%) |
| June 2016 | - | -2082.77%(-14.9%) |
| Mar 2016 | - | -2447.90%(-50.3%) |
| Dec 2015 | -10.42 K% | -4925.51% |
FAQ
- What is CRISPR Therapeutics AG annual operating profit margin?
- What is the all time high annual operating margin for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual operating margin year-on-year change?
- What is the all time high quarterly operating margin for CRISPR Therapeutics AG?
What is CRISPR Therapeutics AG annual operating profit margin?
The current annual operating margin of CRSP is -60.15%
What is the all time high annual operating margin for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual operating profit margin is 40.91%
What is CRISPR Therapeutics AG annual operating margin year-on-year change?
Over the past year, CRSP annual operating profit margin has changed by +154.33 K% (+99.96%)
What is the all time high quarterly operating margin for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly operating profit margin is 84.72%